𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The cost of treatment for child pneumonias and meningitis in the Northern Areas of Pakistan

✍ Scribed by Hamidah Hussain; Hugh Waters; Saad B. Omer; Aamir Khan; Imam Yar Baig; Rozina Mistry; Neal Halsey


Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
74 KB
Volume
21
Category
Article
ISSN
0749-6753

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Pneumonia, meningitis, and sepsis place a significant economic burden on health care systems, particularly in developing countries. This study estimates treatment costs for these diseases in health facilities in the Northern Areas of Pakistan. Health facility resources are organized by categories—including salaries, capital costs, utilities, overhead, maintenance and supplies—and quantified using activity‐based costing (ABC) techniques. The average cost of treatment for an outpatient case of child pneumonia is $13.44. For hospitalized care, the health system spent an average of $71 per episode for pneumonia, $235 for severe pneumonia, and $2,043 for meningitis. These costs provide important background information for the potential introduction of the conjugate Haemophilus influenzae type b (Hib) and Streptococcus pneumoniae vaccines in Pakistan. Copyright © 2006 John Wiley & Sons, Ltd.


📜 SIMILAR VOLUMES


The Cochrane Library and Treatment for C
✍ Kelly Russell; Joan Robinson; Diane Yorke; Inge Axelsson 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 138 KB 👁 2 views

## Abstract ## Background Globally, pneumonia is the leading cause of death among children and also results in significant morbidity. The most common treatment options include anti‐pyretics and antibiotics. Other treatments include vitamins and over‐the‐counter cough syrup. ## Objective This ove

Cost-effectiveness analysis of trastuzum
✍ Louis P. Garrison Jr; Deborah Lubeck; Deepa Lalla; Virginia Paton; Amylou Dueck; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB 👁 2 views

## Abstract ## BACKGROUND. Adding trastuzumab to adjuvant chemotherapy provides significant clinical benefit in patients with human epidermal growth factor receptor 2 (HER2)‐positive breast cancer. A cost‐effectiveness analysis was performed to assess clinical and economic implications of adding t

Development of a clinical prediction mod
✍ Frank E. Harrell Jr.; Peter A. Margolis; Sandy Gove; Karen E. Mason; E. Kim Mulh 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 542 KB

This paper describes the methodologies used to develop a prediction model to assist health workers in developing countries in facing one of the most difficult health problems in all parts of the world: the presentation of an acutely ill young infant. Statistical approaches for developing the clinica